Please enable JavaScript to continue using this application.

Compare $ELTX vs $EXOZ | Chartloom

Compare

$ELTX vs $EXOZ

Elicio Therapeutics Inc · eXoZymes Inc

ELTX

Elicio Therapeutics Inc

EXOZ

eXoZymes Inc

Compare $ELTX vs $EXOZ

Comparing Elicio Therapeutics Inc and eXoZymes Inc

ELTXElicio Therapeutics Inc

EXOZeXoZymes Inc

ELTXElicio Therapeutics Inc

Market cap

$44M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-91.9%

YTD performance

-76.5%

52W performance

-82.0%

FCF yield

-86.7%

EXOZeXoZymes Inc

Market cap

$49M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-52.2%

52W performance

-66.1%

FCF yield

-14.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ELTX

EXOZ

Detailed metrics comparison

ELTX

Elicio Therapeutics Inc

EXOZ

eXoZymes Inc

Market Cap

ELTX$44M

EXOZ$49M

Enterprise Value

ELTX$30M

EXOZ$43M

Price

ELTX$1.89

EXOZ$5.25

P/E Ratio

ELTXN/A

EXOZN/A

P/S Ratio

ELTX1.70x

EXOZ0.00x

EV/Sales

ELTX0.00x

EXOZ0.00x

EV/EBITDA

ELTX0.00x

EXOZ0.00x

P/B Ratio

ELTX6.36x

EXOZ14.66x

P/FCF Ratio

ELTXN/A

EXOZN/A

EV/FCF

ELTX-0.78x

EXOZ-6.04x

PEG Ratio

ELTXN/A

EXOZN/A

Forward P/E (NTM)

ELTXN/A

EXOZN/A

Forward P/S (NTM)

ELTXN/A

EXOZN/A

Revenue (TTM)

ELTX$0

EXOZ$0

Revenue Growth (YoY)

ELTX-91.9%

EXOZN/A

Forward Rev Growth

ELTX152.2%

EXOZ0.0%

Gross Margin (TTM)

ELTX98.5%

EXOZ0.0%

Operating Margin (TTM)

ELTX0.0%

EXOZ0.0%

EBITDA Margin (TTM)

ELTX0.0%

EXOZ0.0%

Net Margin (TTM)

ELTX0.0%

EXOZ0.0%

FCF Margin (TTM)

ELTXN/A

EXOZN/A

Net Income (TTM)

ELTX$-38M

EXOZ$-10M

FCF (TTM)

ELTX$-38M

EXOZ$-7M

EPS (TTM)

ELTX-$1.97

EXOZ-$1.18

ROE (TTM)

ELTX-58297.0%

EXOZ-29213.0%

ROA (TTM)

ELTX-13994.0%

EXOZ-15866.0%

ROIC (TTM)

ELTX-18562.0%

EXOZ-28374.0%

Cash

ELTX$23M

EXOZ$6M

Debt

ELTX$10M

EXOZ$87K

Net Cash/Debt

ELTX$14M

EXOZ$6M

Current Ratio (TTM)

ELTX2.77x

EXOZ3.81x

Quick Ratio (TTM)

ELTX2.55x

EXOZ3.63x

Debt/Equity (TTM)

ELTX1.20x

EXOZ0.02x

Debt/Assets (TTM)

ELTX0.0%

EXOZ0.0%

Interest Coverage (TTM)

ELTXN/A

EXOZN/A

Net Debt/EBITDA (TTM)

ELTX0.00x

EXOZ0.00x

Beta

ELTX1.65

EXOZ1.20

52W Performance

ELTX-82.0%

EXOZ-66.1%

YTD Performance

ELTX-76.5%

EXOZ-52.2%

% from 52W High

ELTX-88.2%

EXOZ-71.5%

% from 52W Low

ELTX10.9%

EXOZ20.7%

Asset Turnover (TTM)

ELTX0.33x

EXOZ0.00x

FCF Yield (TTM)

ELTX-86.7%

EXOZ-14.7%

Earnings Yield (TTM)

ELTX-87.0%

EXOZ-20.9%

Dividend Yield (TTM)

ELTXN/A

EXOZN/A

Rule of 40

ELTX-91.9

EXOZ0.0

EV/GP/RG

ELTXN/A

EXOZN/A

Ticker research

View ELTX research View EXOZ research

Metric	ELTX Elicio Therapeutics Inc	EXOZ eXoZymes Inc
Market & Valuation
Market Cap	$44M	$49M
Enterprise Value	$30M	$43M
Price	$1.89	$5.25
P/E Ratio	N/A	N/A
P/S Ratio	1.70x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	6.36x	14.66x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.78x	-6.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-91.9%	N/A
Forward Rev Growth	152.2%	0.0%
Profitability
Gross Margin (TTM)	98.5%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-38M	$-10M
FCF (TTM)	$-38M	$-7M
EPS (TTM)	-$1.97	-$1.18
ROE (TTM)	-58297.0%	-29213.0%
ROA (TTM)	-13994.0%	-15866.0%
ROIC (TTM)	-18562.0%	-28374.0%
Financial Health
Cash	$23M	$6M
Debt	$10M	$87K
Net Cash/Debt	$14M	$6M
Current Ratio (TTM)	2.77x	3.81x
Quick Ratio (TTM)	2.55x	3.63x
Debt/Equity (TTM)	1.20x	0.02x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.65	1.20
52W Performance	-82.0%	-66.1%
YTD Performance	-76.5%	-52.2%
% from 52W High	-88.2%	-71.5%
% from 52W Low	10.9%	20.7%
Efficiency & Yields
Asset Turnover (TTM)	0.33x	0.00x
FCF Yield (TTM)	-86.7%	-14.7%
Earnings Yield (TTM)	-87.0%	-20.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-91.9	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ELTX research	View EXOZ research

Valuation

P/S Ratio

EXOZ

0.00x

ELTX

1.70x

EV/FCF

EXOZ

-6.04x

ELTX

-0.78x

Growth & revenue

Revenue Growth TTM

ELTX

-91.9%

Forward Revenue Growth

ELTX

152.2%

EXOZ

0.0%

Profitability & performance

Gross Margin

ELTX

98.5%

EXOZ

0.0%

ROE

EXOZ

-29213.0%

ELTX

-58297.0%

FCF Yield %

EXOZ

-14.7%

ELTX

-86.7%

52-Week Performance

EXOZ

-66.1%

ELTX

-82.0%

Detailed metrics comparison

ELTX

Elicio Therapeutics Inc

EXOZ

eXoZymes Inc

Market Cap

ELTX$44M

EXOZ$49M

Enterprise Value

ELTX$30M

EXOZ$43M

Price

ELTX$1.89

EXOZ$5.25

P/E Ratio

ELTXN/A

EXOZN/A

P/S Ratio

ELTX1.70x

EXOZ0.00x

EV/Sales

ELTX0.00x

EXOZ0.00x

EV/EBITDA

ELTX0.00x

EXOZ0.00x

P/B Ratio

ELTX6.36x

EXOZ14.66x

P/FCF Ratio

ELTXN/A

EXOZN/A

EV/FCF

ELTX-0.78x

EXOZ-6.04x

PEG Ratio

ELTXN/A

EXOZN/A

Forward P/E (NTM)

ELTXN/A

EXOZN/A

Forward P/S (NTM)

ELTXN/A

EXOZN/A

Revenue (TTM)

ELTX$0

EXOZ$0

Revenue Growth (YoY)

ELTX-91.9%

EXOZN/A

Forward Rev Growth

ELTX152.2%

EXOZ0.0%

Gross Margin (TTM)

ELTX98.5%

EXOZ0.0%

Operating Margin (TTM)

ELTX0.0%

EXOZ0.0%

EBITDA Margin (TTM)

ELTX0.0%

EXOZ0.0%

Net Margin (TTM)

ELTX0.0%

EXOZ0.0%

FCF Margin (TTM)

ELTXN/A

EXOZN/A

Net Income (TTM)

ELTX$-38M

EXOZ$-10M

FCF (TTM)

ELTX$-38M

EXOZ$-7M

EPS (TTM)

ELTX-$1.97

EXOZ-$1.18

ROE (TTM)

ELTX-58297.0%

EXOZ-29213.0%

ROA (TTM)

ELTX-13994.0%

EXOZ-15866.0%

ROIC (TTM)

ELTX-18562.0%

EXOZ-28374.0%

Cash

ELTX$23M

EXOZ$6M

Debt

ELTX$10M

EXOZ$87K

Net Cash/Debt

ELTX$14M

EXOZ$6M

Current Ratio (TTM)

ELTX2.77x

EXOZ3.81x

Quick Ratio (TTM)

ELTX2.55x

EXOZ3.63x

Debt/Equity (TTM)

ELTX1.20x

EXOZ0.02x

Debt/Assets (TTM)

ELTX0.0%

EXOZ0.0%

Interest Coverage (TTM)

ELTXN/A

EXOZN/A

Net Debt/EBITDA (TTM)

ELTX0.00x

EXOZ0.00x

Beta

ELTX1.65

EXOZ1.20

52W Performance

ELTX-82.0%

EXOZ-66.1%

YTD Performance

ELTX-76.5%

EXOZ-52.2%

% from 52W High

ELTX-88.2%

EXOZ-71.5%

% from 52W Low

ELTX10.9%

EXOZ20.7%

Asset Turnover (TTM)

ELTX0.33x

EXOZ0.00x

FCF Yield (TTM)

ELTX-86.7%

EXOZ-14.7%

Earnings Yield (TTM)

ELTX-87.0%

EXOZ-20.9%

Dividend Yield (TTM)

ELTXN/A

EXOZN/A

Rule of 40

ELTX-91.9

EXOZ0.0

EV/GP/RG

ELTXN/A

EXOZN/A

Ticker research

View ELTX research View EXOZ research

Metric	ELTX Elicio Therapeutics Inc	EXOZ eXoZymes Inc
Market & Valuation
Market Cap	$44M	$49M
Enterprise Value	$30M	$43M
Price	$1.89	$5.25
P/E Ratio	N/A	N/A
P/S Ratio	1.70x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	6.36x	14.66x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.78x	-6.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-91.9%	N/A
Forward Rev Growth	152.2%	0.0%
Profitability
Gross Margin (TTM)	98.5%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-38M	$-10M
FCF (TTM)	$-38M	$-7M
EPS (TTM)	-$1.97	-$1.18
ROE (TTM)	-58297.0%	-29213.0%
ROA (TTM)	-13994.0%	-15866.0%
ROIC (TTM)	-18562.0%	-28374.0%
Financial Health
Cash	$23M	$6M
Debt	$10M	$87K
Net Cash/Debt	$14M	$6M
Current Ratio (TTM)	2.77x	3.81x
Quick Ratio (TTM)	2.55x	3.63x
Debt/Equity (TTM)	1.20x	0.02x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.65	1.20
52W Performance	-82.0%	-66.1%
YTD Performance	-76.5%	-52.2%
% from 52W High	-88.2%	-71.5%
% from 52W Low	10.9%	20.7%
Efficiency & Yields
Asset Turnover (TTM)	0.33x	0.00x
FCF Yield (TTM)	-86.7%	-14.7%
Earnings Yield (TTM)	-87.0%	-20.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-91.9	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ELTX research	View EXOZ research